Actavis - Recent News & Activity
Prescription Addiction: Big Pharma and the Opioid Epidemic
Orexo Annual Report 2016
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
EX-99.1
MRx Pipeline October 2023 by Magellan Rx Management - Issuu
Orexo — The opioid use disorder patient journey - Edison Group
Annual Report
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Opioid Dependence Treatment Market Size, Share Forecast 2035
EX-99.1
Orexo Patent for Opioid Dependency Treatment Blocks Actavis' Generic
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Orexo sues Actavis and Teva over narcotic dependency treatment | Life Sciences Intellectual Property Review
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Type headline here
Type headline here
Actavis - Recent News & Activity
AL-SF-01122
Addiction therapeutics market size to increase by USD 9.86 billion between 2022 and 2027; Driven by high consumption of alcohol, tobacco, and opioid products - Technavio
Importance of personalized therapies | Deloitte Insights
Orexo soars after winning opioid drug appeal against Teva | Reuters
Orexo — The opioid use disorder patient journey - Edison Group
Orexo Acquires Exclusive US Rights to Commercialize deprexis - IndiaMedToday
